Literature DB >> 22863425

Diabetic gastrointestinal autonomic neuropathy: current status and new achievements for everyday clinical practice.

A Gatopoulou1, N Papanas, E Maltezos.   

Abstract

Gastrointestinal symptoms occur frequently among patients with diabetes mellitus and are associated with considerable morbidity. Diabetic gastrointestinal autonomic neuropathy represents a complex disorder with multifactorial pathogenesis, which is still not well understood. It appears to involve a spectrum of metabolic and cellular changes that affect gastrointestinal motor and sensory control. It may affect any organ in the digestive system. Clinical manifestations are often underestimated, and therefore autonomic neuropathy should be suspected in all diabetic patients with unexplained gastrointestinal symptoms. Advances in technology have now enabled assessment of gastrointestinal motor function. Moreover, novel pharmacological approaches, along with endoscopic and surgical treatment options, contribute to improved outcomes. This review summarises the progress achieved in diabetic gastrointestinal autonomic neuropathy during the last years, focusing on clinical issues of practical importance to the everyday clinician.
Copyright © 2012 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22863425     DOI: 10.1016/j.ejim.2012.03.001

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  24 in total

1.  Combination of symptoms, syndrome and disease: treatment of refractory diabetic gastroparesis.

Authors:  Jun-Ling Li; Min Li; Bing Pang; Qiang Zhou; Jia-Xing Tian; Hong-Xing Liu; Xi-Yan Zhao; Xiao-Lin Tong
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

2.  Severe gastrointestinal autonomic dysfunction in a diabetic boy.

Authors:  Pedro Marques; Luís Varandas; Lurdes Lopes
Journal:  Endocrine       Date:  2015-03-10       Impact factor: 3.633

3.  Cirrhotic Patients Have Worse Bowel Preparation at Screening Colonoscopy than Chronic Liver Disease Patients without Cirrhosis.

Authors:  Anika K Anam; Kunal Karia; Arun B Jesudian; Brian P Bosworth
Journal:  J Clin Exp Hepatol       Date:  2016-08-31

Review 4.  Diabetes-related dysfunction of the small intestine and the colon: focus on motility.

Authors:  Viktor József Horváth; Zsuzsanna Putz; Ferenc Izbéki; Anna Erzsébet Körei; László Gerő; Csaba Lengyel; Péter Kempler; Tamás Várkonyi
Journal:  Curr Diab Rep       Date:  2015-11       Impact factor: 4.810

5.  Expression of Cocaine and Amphetamine Regulated Transcript (CART) in the Porcine Intramural Neurons of Stomach in the Course of Experimentally Induced Diabetes Mellitus.

Authors:  Michał Bulc; Sławomir Gonkowski; Jarosław Całka
Journal:  J Mol Neurosci       Date:  2015-08-13       Impact factor: 3.444

6.  Exercise-mediated improvements in painful neuropathy associated with prediabetes in mice.

Authors:  Anna L Groover; Janelle M Ryals; Brianne L Guilford; Natalie M Wilson; Julie A Christianson; Douglas E Wright
Journal:  Pain       Date:  2013-08-06       Impact factor: 6.961

Review 7.  Treating Diabetic Neuropathy: Present Strategies and Emerging Solutions.

Authors:  Saad Javed; Uazman Alam; Rayaz A Malik
Journal:  Rev Diabet Stud       Date:  2015-08-10

8.  Mild diabetes: long-term effects on gastric motility evaluated in rats.

Authors:  Andrieli T Hauschildt; Luciana A Corá; Gustavo T Volpato; Yuri K Sinzato; Débora C Damasceno; Madileine F Américo
Journal:  Int J Exp Pathol       Date:  2018-02-26       Impact factor: 1.925

9.  Loss of gastric interstitial cells of Cajal in patients with hereditary transthyretin amyloidosis.

Authors:  Jonas Wixner; Konen Obayashi; Yukio Ando; Pontus Karling; Intissar Anan
Journal:  Amyloid       Date:  2013-05-03       Impact factor: 7.141

10.  Complications of Diabetes.

Authors:  Konstantinos Papatheodorou; Maciej Banach; Michael Edmonds; Nikolaos Papanas; Dimitrios Papazoglou
Journal:  J Diabetes Res       Date:  2015-07-12       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.